PL2391654T3 - Biomarkery w moczu i surowicy związane z nefropatią cukrzycową - Google Patents
Biomarkery w moczu i surowicy związane z nefropatią cukrzycowąInfo
- Publication number
- PL2391654T3 PL2391654T3 PL10735454T PL10735454T PL2391654T3 PL 2391654 T3 PL2391654 T3 PL 2391654T3 PL 10735454 T PL10735454 T PL 10735454T PL 10735454 T PL10735454 T PL 10735454T PL 2391654 T3 PL2391654 T3 PL 2391654T3
- Authority
- PL
- Poland
- Prior art keywords
- urine
- diabetic nephropathy
- biomarkers associated
- serum biomarkers
- serum
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4728—Details alpha-Glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
- G01N2333/8125—Alpha-1-antitrypsin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14777809P | 2009-01-28 | 2009-01-28 | |
| PCT/CA2010/000097 WO2010085879A1 (en) | 2009-01-28 | 2010-01-27 | Urine and serum biomarkers associated with diabetic nephropathy |
| EP10735454.0A EP2391654B1 (en) | 2009-01-28 | 2010-01-27 | Urine and serum biomarkers associated with diabetic nephropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2391654T3 true PL2391654T3 (pl) | 2016-04-29 |
Family
ID=42395076
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10735454T PL2391654T3 (pl) | 2009-01-28 | 2010-01-27 | Biomarkery w moczu i surowicy związane z nefropatią cukrzycową |
| PL13162626T PL2623517T3 (pl) | 2009-01-28 | 2010-01-27 | Biomarkery w moczu i surowicy związane z nefropatią cukrzycową |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13162626T PL2623517T3 (pl) | 2009-01-28 | 2010-01-27 | Biomarkery w moczu i surowicy związane z nefropatią cukrzycową |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US8465980B2 (pl) |
| EP (2) | EP2391654B1 (pl) |
| JP (1) | JP5689426B2 (pl) |
| CN (1) | CN102300877B (pl) |
| BR (1) | BRPI1007443B8 (pl) |
| CA (1) | CA2748937C (pl) |
| DK (2) | DK2623517T3 (pl) |
| ES (2) | ES2552557T3 (pl) |
| HU (2) | HUE025795T2 (pl) |
| MX (1) | MX2011007811A (pl) |
| PL (2) | PL2391654T3 (pl) |
| PT (2) | PT2391654E (pl) |
| TW (1) | TWI449910B (pl) |
| WO (1) | WO2010085879A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2391653T3 (en) * | 2009-01-28 | 2015-02-09 | Ind Tech Res Inst | Biomarkers associated nephropathy |
| JP6271250B2 (ja) * | 2010-09-21 | 2018-01-31 | プロテオミクス インターナショナル プロプライエタリー リミテッドＰｒｏｔｅｏｍｉｃｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐｔｙ Ｌｔｄ | 糖尿病前症、糖尿病、および糖尿病関連症状に関連するバイオマーカー |
| JP5714285B2 (ja) * | 2010-09-29 | 2015-05-07 | 株式会社プロトセラ | 妊娠高血圧症候群マーカーおよびそれを用いた診断 |
| EP2592421B1 (en) * | 2011-11-14 | 2017-08-30 | Universitätsklinikum Jena | Diagnosis of sepsis and systemic inflammatory response syndrome |
| WO2013115283A1 (ja) * | 2012-01-31 | 2013-08-08 | 味の素株式会社 | 早期腎症の評価方法、早期腎症評価装置、早期腎症評価方法、早期腎症評価プログラム、早期腎症評価システムおよび情報通信端末装置 |
| WO2013122976A1 (en) * | 2012-02-13 | 2013-08-22 | New York University | Osteopontin isoform a inhibitors and methods of use |
| GB201203938D0 (en) * | 2012-03-06 | 2012-04-18 | Binding Site Group The Ltd | Assay system |
| CA2818328C (en) | 2012-06-11 | 2017-09-05 | Preventage Healthcare Llc | Methods for improving diabetes management |
| EP3066476A2 (en) * | 2013-11-04 | 2016-09-14 | The Regents of the University of Michigan | Biomarkers and methods for progression prediction for chronic kidney disease |
| CN103804484B (zh) * | 2014-01-24 | 2016-03-16 | 南京必优康生物技术有限公司 | 一种网红细胞生长因子及其制备方法和应用 |
| CN105572355B (zh) * | 2015-03-13 | 2018-04-13 | 中国医学科学院肿瘤医院 | 检测食管癌的生物标志物 |
| JP2022523564A (ja) | 2019-03-04 | 2022-04-25 | アイオーカレンツ， インコーポレイテッド | 機械学習を使用するデータ圧縮および通信 |
| CN114487431A (zh) * | 2020-11-12 | 2022-05-13 | 首都医科大学附属北京世纪坛医院 | 尿液α-2-HS-糖蛋白及其多肽片段在妊娠糖尿病中的应用 |
| CN113687083B (zh) * | 2021-08-20 | 2023-11-28 | 天津中医药大学 | 一种基于深度学习的糖尿病肾病早期预测方法及系统 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999015904A1 (en) | 1997-09-26 | 1999-04-01 | University Of Washington | Methods and compositions for diagnosing renal pathologies |
| JP2002090365A (ja) * | 2000-02-08 | 2002-03-27 | Internatl Reagents Corp | 腎障害の検査手段 |
| DE60029302T2 (de) * | 2000-04-28 | 2007-08-09 | Bayer Ag | Diagnose von Leberfibrose mit Hilfe von Serummarkeralgorithmen |
| CN1439020A (zh) * | 2000-06-13 | 2003-08-27 | 儿童医学中心公司 | 生物合成的溶瘤分子及其用途 |
| EP1345969B1 (fr) * | 2000-12-26 | 2010-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anticorps anti-cd28 |
| US7297556B2 (en) * | 2001-08-30 | 2007-11-20 | Vermillion, Inc. | Method of diagnosing nephrotic syndrome |
| US20040171081A1 (en) * | 2001-11-23 | 2004-09-02 | Abraham Mittelman | Antigens |
| US20050048574A1 (en) * | 2003-03-14 | 2005-03-03 | Kantor Aaron B. | Biomarkers for diagnosing rheumatoid arthritis |
| US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
| US20050266467A1 (en) * | 2004-05-19 | 2005-12-01 | Ppd Biomarker Discovery Sciences, Llc | Biomarkers for multiple sclerosis and methods of use thereof |
| WO2006044666A2 (en) * | 2004-10-15 | 2006-04-27 | Northeastern University | Detection of disease associated proteolysis by direct mass spectrometry analysis of low molecular weight peptides |
| DE602005020046D1 (de) * | 2005-09-05 | 2010-04-29 | Immatics Biotechnologies Gmbh | Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden |
| US8263342B2 (en) * | 2005-10-27 | 2012-09-11 | Yale University | Urinary proteomic biomarker patterns in preeclampsia |
| US20070111245A1 (en) * | 2005-11-09 | 2007-05-17 | Ravi Thadhani | Predicting diabetic nephropathy |
| WO2007110230A2 (en) * | 2006-03-27 | 2007-10-04 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
| CA2660286A1 (en) * | 2006-08-09 | 2008-02-21 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| WO2008092214A1 (en) | 2007-02-02 | 2008-08-07 | Minomic International Limited | Biomarkers for diabetes |
| EP2479571A3 (en) | 2007-03-26 | 2012-09-26 | Novartis AG | Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
| WO2010031822A1 (de) * | 2008-09-17 | 2010-03-25 | Mosaiques Diagnostics And Therapeutics Ag | Nierenzellkarzinom |
| DK2391653T3 (en) * | 2009-01-28 | 2015-02-09 | Ind Tech Res Inst | Biomarkers associated nephropathy |
-
2010
- 2010-01-27 DK DK13162626.9T patent/DK2623517T3/en active
- 2010-01-27 CN CN201080005751.2A patent/CN102300877B/zh active Active
- 2010-01-27 PT PT107354540T patent/PT2391654E/pt unknown
- 2010-01-27 DK DK10735454.0T patent/DK2391654T3/en active
- 2010-01-27 EP EP10735454.0A patent/EP2391654B1/en active Active
- 2010-01-27 CA CA2748937A patent/CA2748937C/en active Active
- 2010-01-27 BR BRPI1007443A patent/BRPI1007443B8/pt active IP Right Grant
- 2010-01-27 PT PT131626269T patent/PT2623517E/pt unknown
- 2010-01-27 HU HUE10735454A patent/HUE025795T2/en unknown
- 2010-01-27 PL PL10735454T patent/PL2391654T3/pl unknown
- 2010-01-27 WO PCT/CA2010/000097 patent/WO2010085879A1/en not_active Ceased
- 2010-01-27 PL PL13162626T patent/PL2623517T3/pl unknown
- 2010-01-27 ES ES13162626.9T patent/ES2552557T3/es active Active
- 2010-01-27 MX MX2011007811A patent/MX2011007811A/es active IP Right Grant
- 2010-01-27 US US12/694,575 patent/US8465980B2/en active Active
- 2010-01-27 HU HUE13162626A patent/HUE025796T2/hu unknown
- 2010-01-27 EP EP13162626.9A patent/EP2623517B8/en active Active
- 2010-01-27 ES ES10735454.0T patent/ES2552467T3/es active Active
- 2010-01-27 JP JP2011546555A patent/JP5689426B2/ja active Active
- 2010-01-28 TW TW099102367A patent/TWI449910B/zh active
- 2010-12-15 US US12/969,039 patent/US8476077B2/en active Active
- 2010-12-20 US US12/972,936 patent/US20110086371A1/en not_active Abandoned
-
2013
- 2013-05-24 US US13/901,819 patent/US10101340B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2623517E (pt) | Biomarcadores na urina e séricos associados com nefropatia diabética | |
| EP2501826A4 (en) | NUTRIGENETIC BIOMARKERS FOR ADIPOSITAS AND TYPE-2 DIABETES | |
| GB2486155B (en) | Predicting and avoiding operand-store-compare hazards in out- of-order microprocessors | |
| IL233096A0 (en) | Ratio based biomarkers and methods of use thereof | |
| WO2010036342A9 (en) | Urinary biomarkers for predicting long-term dialysis | |
| IL220162A0 (en) | Anti-her3 antibodies and uses thereof | |
| GB0909608D0 (en) | Electrochemical assays | |
| GB2474618B (en) | Predictive biomarkers | |
| GB0914535D0 (en) | Prognosis assay | |
| GB0922097D0 (en) | Microbial assay | |
| GB201109738D0 (en) | Capacitive deinization cell with through-flow | |
| GB0818660D0 (en) | Biomarkers | |
| GB0807214D0 (en) | Biomarkers | |
| GB0919520D0 (en) | Quantifying cell death | |
| EP2391653B8 (en) | Biomarkers associated with nephropathy | |
| GB0821912D0 (en) | Biomarkers | |
| GB0818658D0 (en) | Biomarkers | |
| ZA201204405B (en) | Assay for quantifying neurotoxin | |
| GB0903391D0 (en) | Biomarkers | |
| TWI372015B (en) | Notebook computer with document holding function | |
| GB0912190D0 (en) | Biomarker | |
| GB0812845D0 (en) | Electrochemical assay | |
| GB0922236D0 (en) | Biomarkers | |
| AU2010904249A0 (en) | Biomarkers associated with pre-diabetes,diabetes and diabetes related conditions | |
| GB0905090D0 (en) | Biomarkers |